Dr Nicholas Donohue

Nicholas received his BSc in microbiology from the University of Nottingham in 2012, followed by a PhD at the University of York under supervision of Dr. Marjan van der Woude. His thesis focused on the genetic control of a Salmonella virulence factor that modifies cell wall polysaccharides in the bacteria. From 2016 to 2019, Nicholas worked as a post-doctoral researcher at the Medical University of Graz, Austria on the differentiation and calcium metabolism of mesenchymal stem cells. Currently, he works as a post-doctoral researcher with Prof. Niall Barron on a project funded by Allergan, which aims to improve production methods of adeno-associated viruses for the purpose of gene therapy. Nicholas will focus on vector design and cell engineering